Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02851758 · ClinicalTrials.gov registry record · NA

Transplantation of Autologously Derived Mitochondria Following Ischemia

A NA study of Extracorporeal Membrane Oxygenation Complication, sponsored by Boston Children's Hospital.

Recruiting
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT02851758 is a NA study of Extracorporeal Membrane Oxygenation Complication that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 16 participants, below the 836-participant average among 8 other Extracorporeal Membrane Oxygenation Complication trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02851758, a NA study of Extracorporeal Membrane Oxygenation Complication, is actively recruiting participants, sponsored by Boston Children's Hospital.

RECRUITING
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

The investigators propose a robust therapeutic intervention to ameliorate myocardial ischemia/ reperfusion injury and significantly decrease morbidity and mortality in patients requiring extracorporeal membrane oxygenation (ECMO), by direct injection of autogeneic mitochondria into the ischemic myocardium.

Interventions

  • OTHER autologous mitochondria transplantation

Study Locations (1)

Massachusetts

  • Boston Children's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2017-08-02
Est. Completion 2027-06
Phase NA

Sponsor

Boston Children's Hospital

462 total trials

What the Registry Record Tells You About NCT02851758

The ClinicalTrials.gov registry entry for NCT02851758 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 836-participant average among 8 other Extracorporeal Membrane Oxygenation Complication trials with a reported enrollment target (98% lower). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Extracorporeal Membrane Oxygenation Complication appearing as the primary indexed condition, and to 1 intervention - of which autologous mitochondria transplantation is the first listed.

NCT02851758 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02851758 about?

NCT02851758 is a clinical study titled "Transplantation of Autologously Derived Mitochondria Following Ischemia". The investigators propose a robust therapeutic intervention to ameliorate myocardial ischemia/ reperfusion injury and significantly decrease morbidity and mortality in patients requiring extracorporeal membrane oxygenation (ECMO), by direct injection of autogeneic mitochondria into the ischemic myoc...

What is the current status of trial NCT02851758?

This trial is currently recruiting. It is a NA study. The enrollment target is 16 participants. The study started on 2017-08-02. Estimated completion is 2027-06.

What conditions does trial NCT02851758 study?

This clinical trial studies the following conditions: Extracorporeal Membrane Oxygenation Complication.

What interventions are being tested in trial NCT02851758?

The interventions under investigation include: autologous mitochondria transplantation (OTHER).

Who is sponsoring clinical trial NCT02851758?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02851758 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Extracorporeal Membrane Oxygenation Complication

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.